Low-dose Radiotherapy Combined With Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of ES-SCLC

Stopped Inorder to avoid the serious adverse effect of Toripalimab combining with Tifcemalimab, considering as the protection of participants.

Conditions

• Extensive-stage Small-cell Lung Cancer

Interventions

• RADIATION: Low-dose radiotherapy
• DRUG: Tifcemalimab injection
• DRUG: Toripalimab
• DRUG: Cisplatin
• DRUG: Carboplatin
• DRUG: Etoposide

Sponsor

Sichuan University